Granite Point Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,000
| Closed | -$229K | – | 44 |
|
|
2023
Q1 | $229K | Sell |
3,000
-2,000
| -40% | -$152K | 0.32% | 34 |
|
|
2022
Q4 | $415K | Sell |
5,000
-10,000
| -67% | -$830K | 0.26% | 48 |
|
|
2022
Q3 | $1.19M | Hold |
15,000
| – | – | 0.48% | 24 |
|
|
2022
Q2 | $1.11M | Buy |
+15,000
| New | +$1.11M | 0.28% | 32 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 143 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 139 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 164 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 172 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 189 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 179 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 161 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 134 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 98 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 90 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 83 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 102 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 117 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 113 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 129 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 134 |
|